Sotac Pharmaceuticals Ltd — Quarterly Results & Earnings

₹109.25

+0.00%

Profit Growth YoY28.27%Latest quarter

Sales Growth YoY-29.63%Latest quarter

Sales CAGR 5Y27.65%5 year compound

Profit CAGR 5Y149.51%5 year compound

📋

Quarterly Performance

YoY Profit Growth+28.27%

🔥 Exceptional growth

YoY Sales Growth-29.63%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

82.29%

Interest Coverage

Higher = safer debt servicing

4.46

ROE

15.71%

ROCE

15.06%

💡

Growth Analysis

Sotac Pharmaceuticals Ltd reported YoY profit growth of 28.27% and revenue growth of -29.63% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 27.65% and profits at 149.51% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Sotac Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.